TRICCAR, Inc.
TCCR
Other OTC1.50
USD
+0.29
- -
CIK
0001108645
Return %
Stock
S&P500
1Y
- -
26.84
3Y
- -
77.03
5Y
82.93
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 220 Travis Street Shreveport LA United States of America 71101
- IPO Date
- Dec 23, 2021
- CIK
- 0001108645
- Website
- triccar.com
- Similar Companies
- Business
- TRICCAR, Inc. operates as a biomedical research, development, and marketing enterprise focused on delivering health solutions. The company specializes in crafting both bioceutical products, which are available without requiring FDA approval, and pharmaceutical drugs that seek regulatory clearance for global distribution. Its diverse portfolio addresses numerous common health challenges and ailments in both humans and animals, including areas like metabolic health, pain management, neurological support, and immune system enhancement. TRICCAR leverages significant investment in clinical research for its product pipeline, with strategies for immediate market entry for bioceuticals while pursuing strategic collaborations for pharmaceutical development. The company utilizes patented and proprietary marketing approaches to reach its target consumers. Previously a publicly traded entity, the company transitioned to private ownership in 2021 to navigate global market dynamics. TRICCAR is based in Las Vegas, Nevada.